IL6 and melanoma: Accordingly, matrigel assays demonstrated that IL-6 treatment of shE2F1-expressing melanoma cells rescues their invasive capability, whereas addition of the IL-6 inhibitor led to the strongest reduction of cell motility (Figure 1K).